EMERYVILLE, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary ...
MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of ...
EMERYVILLE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary ...
A dendritic cell and a T-cell are depicted dancing in the foreground, under the dazzling lights reflected from a disco ball. In the background, a malignant cancer cell is depicted dancing with another ...
small enough to be packaged into a single adeno-associated virus (AAV) Data demonstrate compact SMART system optimizations allowing for therapeutically-relevant genome editing EMERYVILLE, Calif., Oct.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback